美國(guó)Genzyme Corporation www.genzyme.com
美國(guó)Genzyme公司創(chuàng)立于1981年，是一家全球性生物技術(shù)公司。在28個(gè)國(guó)家有超過(guò)5000名員工，已經(jīng)在80多個(gè)國(guó)家開(kāi)展銷售和市場(chǎng)推廣。
美國(guó)健贊公司（Genzyme Corporation， NASDAQ: GENZ)是全球較早成立的前十大生物制藥公司，也是前二十大納斯達(dá)克上市公司。其銷售產(chǎn)值排全球前十位，是生物制藥領(lǐng)域的五大企業(yè)之一。作為當(dāng)今世界知名生物技術(shù)公司之一，健贊致力于研究和治療患有嚴(yán)重疾病的病人。于1981年成立于波士頓，現(xiàn)已成長(zhǎng)為年收入超過(guò)30億美元，全球超過(guò)8000名員工的多樣化企業(yè)。一直致力于發(fā)展和應(yīng)用生命科學(xué)中最先進(jìn)的技術(shù)以服務(wù)于醫(yī)學(xué)的需要。它所生產(chǎn)的產(chǎn)品和提供的醫(yī)學(xué)服務(wù)救助著超過(guò)80個(gè)國(guó)家的患者，其產(chǎn)品主要集中于罕見(jiàn)遺傳病、腎病、骨關(guān)節(jié)炎、免疫系統(tǒng)疾病和診斷測(cè)試。健贊公司至今仍在不斷創(chuàng)新，繼續(xù)研究開(kāi)發(fā)基因遺傳、免疫系統(tǒng)疾病、心臟病和癌癥等病癥。
2011年法國(guó)賽諾菲-安萬(wàn)特(Sanofi-Aventis)201億美元收購(gòu)健贊(Genzyme)

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 11,000 employees in locations spanning the globe and 2008 revenues of $4.6 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.
With many established products and services helping patients in nearly 100 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as cardiovascular disease, neurodegenerative diseases, and other areas of unmet medical need.